__timestamp | Bristol-Myers Squibb Company | Sanofi |
---|---|---|
Wednesday, January 1, 2014 | 15879000000 | 31999000000 |
Thursday, January 1, 2015 | 16560000000 | 34861000000 |
Friday, January 1, 2016 | 19427000000 | 34696000000 |
Sunday, January 1, 2017 | 20776000000 | 36221000000 |
Monday, January 1, 2018 | 22561000000 | 35677000000 |
Tuesday, January 1, 2019 | 26145000000 | 37631000000 |
Wednesday, January 1, 2020 | 42518000000 | 37369000000 |
Friday, January 1, 2021 | 46385000000 | 39175000000 |
Saturday, January 1, 2022 | 46159000000 | 45389000000 |
Sunday, January 1, 2023 | 45006000000 | 46033000000 |
Igniting the spark of knowledge
In the competitive landscape of the pharmaceutical industry, revenue growth is a key indicator of success. Over the past decade, Sanofi and Bristol-Myers Squibb Company have been at the forefront, showcasing impressive financial performances. From 2014 to 2023, Sanofi consistently outpaced Bristol-Myers Squibb in revenue, with an average annual revenue of approximately $37.9 billion, compared to Bristol-Myers Squibb's $30.1 billion. Notably, in 2020, Bristol-Myers Squibb experienced a significant surge, increasing its revenue by over 60% from the previous year, closing the gap with Sanofi. By 2023, both companies were neck and neck, with Sanofi slightly ahead at $46 billion. This rivalry highlights the dynamic nature of the pharmaceutical sector, where strategic innovations and market expansions play crucial roles in shaping financial trajectories.
Revenue Insights: Eli Lilly and Company and Sanofi Performance Compared
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Revenue Insights: Merck & Co., Inc. and Bristol-Myers Squibb Company Performance Compared
Revenue Showdown: Sanofi vs argenx SE
Breaking Down Revenue Trends: Sanofi vs Teva Pharmaceutical Industries Limited
Sanofi or Alkermes plc: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Sanofi or HUTCHMED (China) Limited?
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Bristol-Myers Squibb Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.